glp-1 kidney function Glucagon-like peptide-1 receptor agonists in diabetic disease: A review of their kidney and heart protection Potential kidney-protective and other effects
Description
Are there alternative weight management options more suitable for me
Is a $50 copay manageable
The satiety effects diminish
We're with you between appointments, not just during them
Last reviewed: May 28, 2026 Last updated: May 28, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
